Trump’s HHS Nominee Got A Sweetheart Deal From A Foreign Biotech Firm
Tom Price's stock deals resurrect concerns about powerful public officials gaining investment opportunities unavailable to the public.
trump hhs nominee get sweetheart deal foreign biotech firm tom price stock deal resurrect concern powerful public official gain investment opportunity unavailable public